C677T and A1298C MTHFR polymorphisms in the etiology of neural tube defects in Spanish population

被引:0
作者
Revilla, JIG
Hernández, FN
Martín, MTC
Salvador, MT
Romero, JG
机构
[1] Univ Zaragoza, Hosp Miguel Servet, Serv Bioquim Clin, Secc Genet, E-50009 Zaragoza, Spain
[2] Univ Zaragoza, Hosp Miguel Servet, Serv Cirugia Pediat, E-50009 Zaragoza, Spain
[3] Farmaceut Atenc Primaria, Gerencia Santander Lared, Spain
来源
MEDICINA CLINICA | 2003年 / 120卷 / 12期
关键词
neural tube defects; metilentetrahidrofolate reductase; C677T; A1298C;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVE: The etiology of neural tube defects (NTDs) is multifactorial. The presence of mutated genotypes of C677T and A1298C polymorphisms, and their combined heterozygosity, have been considered risk factors; for the occurrence and recurrence of NTDs; in some populations. SUBJECTS AND METHOD: This case-control study included 159 healthy controls, 27 NTDs patients, 28 patients mothers and 23 siblings. The polymorphism study was performed by PCR. For fragment digestion, we used the restriction enzymes Hinf I (C677T) and Mbo 11 (A1298C). RESULTS: There was no significant difference (p = 0.991) in C677T genotypes between controls (CC: 35%, CT: 50% and TT: 15%) and patients (37, 52 and 11%, respectively), patients' mothers (39, 50 and 11%, respectively) and siblings (35, 48 and 17%, respectively). The prevalence of A1298C genotypes in controls (AA: 49%, AC: 45% and CC: 6%) was similar (p = 0.917) to the prevalence in patients (41, 56 and 4%, respectively), patients mothers (43, 50 and 7%, respectively) and siblings (52, 39 and 9%, respectively). CONCLUSIONS: The absence of differences in the two polymorphisms between these groups makes us conclude that there is no association with NTDs in the Spanish population.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 32 条
  • [1] Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas Hispanic population
    Barber, R
    Shalat, S
    Hendricks, K
    Joggerst, B
    Larsen, R
    Suarez, L
    Finnell, R
    [J]. MOLECULAR GENETICS AND METABOLISM, 2000, 70 (01) : 45 - 52
  • [2] Boduroglu K, 1998, ARCH DIS CHILD-FETAL, V78, pF235
  • [3] Chen J, 1996, CANCER RES, V56, P4862
  • [4] The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy
    de Franchis, R
    Buoninconti, A
    Mandato, C
    Pepe, A
    Sperandeo, MP
    Del Gado, R
    Capra, V
    Salvaggio, E
    Andria, G
    Mastroiacovo, P
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (12) : 1009 - 1013
  • [5] ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142
  • [6] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE
    FROSST, P
    BLOM, HJ
    MILOS, R
    GOYETTE, P
    SHEPPARD, CA
    MATTHEWS, RG
    BOERS, GJH
    DENHEIJER, M
    KLUIJTMANS, LAJ
    VANDENHEUVEL, LP
    ROZEN, R
    [J]. NATURE GENETICS, 1995, 10 (01) : 111 - 113
  • [7] HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE - ISOLATION OF CDNA, MAPPING AND MUTATION IDENTIFICATION
    GOYETTE, P
    SUMNER, JS
    MILOS, R
    DUNCAN, AMV
    ROSENBLATT, DS
    MATTHEWS, RG
    ROZEN, R
    [J]. NATURE GENETICS, 1994, 7 (02) : 195 - 200
  • [8] Harmon DL, 1996, QJM-MON J ASSOC PHYS, V89, P571
  • [9] Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
    Jacques, PF
    Bostom, AG
    Williams, RR
    Ellison, RC
    Eckfeldt, JH
    Rosenberg, IH
    Selhub, J
    Rozen, R
    [J]. CIRCULATION, 1996, 93 (01) : 7 - 9
  • [10] Johnson WG, 1999, AM J MED GENET, V87, P407, DOI 10.1002/(SICI)1096-8628(19991222)87:5<407::AID-AJMG7>3.3.CO